EZH2 mutations have been described in numerous cancer types including melanoma, hematologic malignancies, breast cancer, prostate cancer, liver and biliary cancers, lung cancer, and endometrial cancer, while EZH2A692V hotspot mutations have been most commonly described in follicular lymphoma and diffuse large B cell lymphoma18–25. Here, EZH2 is linked to prostate carcinoma.